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2004). Yet, little has been known about changes in the expression 
of ubiquitination machinery in human cortex across the lifespan 
into normal, healthy aging.
Ube3A, an E3 ubiquitin ligase, is absent in the neurodevelop-
mental disorder, Angelman’s syndrome, leading to mental retarda-
tion early in life (Kishino et al., 1997). A recent study has shown 
that Ube3A is necessary for experience-dependent ocular domi-
nance plasticity during development (Yashiro et al., 2009). Ube3A 
knockout mice are resistant to the synaptic plasticity that underlies 
monocular deprivation driven changes in ocular dominance. This 
rigidity of synapses is strikingly similar to the reduced experience-
dependent plasticity seen in older animals, who also show no shift 
in ocular dominance patterns when challenged with monocular 
deprivation (Sato and Stryker, 2008).
Neuronal activity interacts with ubiquitination pathways to 
regulate synaptic structure and function in response to changes 
in synaptic activity; for example, by facilitating the functional 
reorganization of the synapse by remodeling the post-synaptic 
density composition (Ehlers, 2003). Furthermore, disruptions in 
ubiquitination pathways are linked with specific neurodegenera-
tive diseases including Alzheimer’s and Parkinson’s disease (Ardley 
and Robinson, 2004). Finally, a recent study has shown that an 
E3 ligase homologous to Ube3A is necessary for caloric restric-
tion to extend longevity (Carrano et al., 2009). It is clear that an 
IntroductIon
A common way of describing the behavior of older adults is that 
they are more rigid and set in their ways. The wide range in sen-
sory and cognitive functional changes that accompany normal, 
healthy aging are suggestive of widespread cortical dysfunction. 
Neurobiological studies are beginning to link these functional 
changes and common descriptions with a loss of experience-
dependent plasticity that reflects age-related changes in synaptic 
plasticity mechanisms (Burke and Barnes, 2006). In the visual 
system, age-related changes include perceptual changes in lumi-
nance, color, motion, and texture (Faubert, 2002), and neurophys-
iological loss of orientation tuning (Schmolesky et al., 2000) and 
ocular dominance plasticity (Sato and Stryker, 2008). The com-
mon explanation for these changes is a loss of GABA-mediated 
inhibition in the aging visual cortex because application of GABA 
to visual cortical neurons reinstates normal receptive field tun-
ing properties (Leventhal et al., 2003). But many changes occur 
at the aging synapse (Wong et al., 2000; Bai et al., 2004), and it is 
likely that more than just one synaptic mechanism contributes 
to visual deficits in aging. Recent studies have highlighted the 
important role of ubiquitin-mediated degradation of proteins at 
the synapse as a potent mechanism for changing synaptic struc-
ture and function (DiAntonio and Hicke, 2004), and the loss of 
ubiquitin ligases in neurodegeneration (Ardley and Robinson, 
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  appropriate balance between synaptic proteins determines synaptic 
efficacy and function, and thus a controlled regulation between 
their  synthesis  and  degradation  is  important  for  maintaining 
normal synaptic transmission and plasticity (Cline, 2003). Taken 
together, these results led us to ask whether normal aging in visual 
cortex is characterized by a loss of Ube3A at the synapse.
To better understand age-related changes in Ube3A expression 
in the visual cortex we quantified expression levels in tissue samples 
from macaque monkey, cat, and human visual cortex. In addition, 
we compared changes in primary visual cortex with extrastriate 
areas, auditory, and frontal cortex. We found a progressive loss of 
Ube3A expression in visual cortex during aging that was similar 
for the three species and cortical areas. Furthermore, our findings 
reveal a selective age-related loss of Ube3A in human cortex that 
becomes apparent at the transition into old age and may signify a 
loss of cortical plasticity.
MaterIals and Methods
tIssue collectIon
Human cortical tissue samples were obtained from the Brain and 
Tissue Bank for Developmental Disorders at the University of 
Maryland (Baltimore, MD, USA). Tissue samples were obtained 
within 24 h postmortem. The occipital lobe was dissected accord-
ing to gyral and sulcal landmarks. The samples were from close 
to the posterior pole of the left hemisphere of human primary 
visual cortex, including both superior and inferior portions of the 
calcarine fissure. At the Brain and Tissue Bank the left hemisphere 
was sectioned coronally, rinsed with water, blotted dry, placed in 
a quick-freeze bath (dry ice and isopentane), and stored frozen 
(−70°C). Samples were from 28 individuals ranging in age from 
20 days to 79 years of age (Table 1). The individuals had no history 
of neurological or mental health disorders.
Macaque  monkey  tissue  samples  were  obtained  from  the 
Alzheimer’s Research Center at the Medical College of Georgia 
(Augusta, GA, USA). Samples were from eight macaque monkeys, 
ranging in age from 4 to 33 years old (Table 2). The right hemi-
sphere was removed, cut into thick coronal sections, fresh frozen, 
and stored at −80°C. The sections used were from the posterior 
pole of the hemisphere including primary visual cortex (V1) and 
extrastriate areas V3a and V4v.
Cat tissue samples were obtained from seven animals, ranging 
in age from 2.5 to 11 years old (Table 3). Samples were collected 
from primary visual cortex (V1), frontal cortex, and auditory cortex 
(A1). Cats were euthanized with Euthanol (165 mg/kg), and tran-
scardially perfused with cold 0.1 M PBS (4°C; 80–100 ml/min) until 
the circulating fluid was cleared. The brain was quickly removed 
from the skull and immersed in cold PBS. To facilitate quantifica-
tion of regional differences within V1, the area was divided into a 
series of small tissue samples (approximately 2 × 2 mm) covering 
the central, peripheral, and monocular visual field representations 
(Tusa et al., 1978). For each cat, two samples of both central and 
peripheral and one from the monocular visual field representation 
were used. Each cortical tissue sample was rapidly frozen on dry 
ice and stored at −80°C.
All experimental procedures were approved by the McMaster 
University Animal Research Ethics Board and the McMaster Human 
Research Ethics Board.
tIssue saMple preparatIon
Pieces of tissue (50–100 mg) were cut from the coronal sections of 
human and macaque monkey cortex using the gyral and sulcal pat-
tern to identify primary visual cortex (V1), presumptive areas V3a, 
and V4v. For the cat the whole 2 × 2 mm pieces of tissue samples 
were used to prepare the samples for Western blotting. Samples were 
suspended in cold homogenization buffer (1 ml buffer:50 mg tissue, 
0.5 mM DTT, 1 mM EDTA, 2 mM EGTA, 10 mM HEPES, 10 mg/l 
Table  | Human tissue samples.
Human 
age
Postmortem 
interval (h)
Sex Cause of death V V3 V4
Days
20 14 F Pneumonia 
86 23 F Not known 
96 12 M Bronchopneumonia 
98 16 M Cardiovascular 
disorder

119 22 M Bronchopneumonia 
120 23 M Pneumonia 
133 16 M Accidental 
136 11 F Pneumonia 
273 10 M Sudden infant death 
syndrome

Years
1.34 21 M Dehydration 
2.16 21 F Cardiovascular 
disorder

3.34 11 F Accidental 
4.56 15 M Accidental 
5.39 17 M Accidental 
8.14 20 F Asphyxia   
8.59 20 F Surgical 
complications
  
9.13 20 F Asthma   
12.45 22 M Cardiovascular 
disorder
  
13.27 5 M Asphyxia   
15.22 16 M Multiple injuries   
19.21 16 F Multiple injuries   
22.98 4 M Multiple injuries   
32.61 13 M Cardiovascular 
disorder
  
50.43 8 M Cardiovascular 
disorder
 
53.90 5 F Cardiovascular 
disorder
  
69.30 12 M Cardiovascular 
disorder
  
71.91 9 F Multiple medical 
disorders
  
79.50 14 F Drug overdose   
The	age	and	postmortem	interval	for	each	of	the	human	cortical	tissue	samples.	
The	star	()	indicates	that	a	sample	was	obtained	from	that	visual	cortical	area.Frontiers in Aging Neuroscience  www.frontiersin.org  May 2010  | Volume 2  | Article 18  |  3
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leupeptin, 100 nM microcystin, 0.1 mM PMSF, 50 mg/l soybean 
trypsin inhibitor) and homogenized using a glass-glass Dounce tis-
sue homogenizer. A portion of the homogenate was removed, the 
remainder was then subjected to a subcellular fractionation proce-
dure in order to enrich for synaptic proteins. Remaining homogenate 
was taken up with a 3-ml syringe, where it was passed through a 5-μm 
pore hydrophillic filter (Millipore, Billerica, MA, USA). The filtered 
product was then centrifuged for 10 minutes at ×1000g. Supernatant 
was removed, leaving a pellet enriched for synaptic proteins, the 
synaptoneurosome. The pellet, homogenate, and supernatant were 
then re-suspended in 100 μl of 1% boiling SDS and then stored at 
−20°C. Protein concentrations were determined using bicinchoninic 
acid (BCA) assay guidelines (Pierce, Rockford, IL, USA). Samples 
from cat were synaptoneurosome preparations, while human and 
macaque samples were homogenate preparations.
IMMunoblottIng
Samples (25 μg) were separated on polyacrylamide (SDS–PAGE) 
mini-gels (Precise Protein Gels) (Pierce Biotechnology Inc, Rockford, 
IL, USA) and transferred to polyvinylidene difluoride (PVDF-FL) 
(Millipore,  Billerica,  MA,  USA)  membranes.  Each  sample  was 
run twice. Blots were pre-incubated in blocking buffer (Odyssey 
Blocking  Buffer  1:1  with  PBS)  for  1  hour  (Li-cor  Biosciences; 
Lincoln, NE, USA), after which blots were incubated in primary anti-
body overnight at 4°C using the following concentrations: Ube3A 
(E6AP),  1:1000;  (Bethyl  Laboratories,  Montgomery,  TX,  USA), 
Synapsin; 1:8000 (Invitrogen, Carlsbad, CA, USA), Synaptophysin; 
1:2000 (Sigma, St. Louis, MO, USA), PSD95; 1:32,000 (Chemicon 
International, Temecula, CA, USA), Gephyrin; 1:2000 (Imgenex, 
San Diego, CA, USA), GAPDH; 1:4000 (Imgenex, San Diego, CA, 
USA). The blots were washed with phosphate buffer saline contain-
ing 0.05% Tween (Sigma, St. Louis, MO, USA) (PBS-T) (3 × 10 min), 
incubated (1 h, room temperature) with the appropriate IRDye 
labeled  secondary  antibody,  (Anti-Mouse,  1:8000,  Anti-Rabbit, 
1:10,000) (Li-cor Biosciences, Lincoln, NE, USA), and washed in 
PBS-T (3 × 10 min). The blots were visualized using the Odyssey 
scanner (Li-cor Biosciences, Lincoln, NE, USA). The IRDye sec-
ondary antibodies and Odyssey scanner system have a wide linear 
dynamic range so that strong and weak bands could be accurately 
quantified on the same blot. The blots were stripped and prepared 
to be reprobed with additional antibodies (Blot Restore Membrane 
Rejuvenation kit, Chemicon International, Temecula, CA, USA).
analysIs
To analyze the expression levels we scanned the blots (Odyssey 
Infrared Scanner) and quantified the bands using densitometry 
(Li-cor Odyssey Software version 3.0; Li-cor Biosciences; Lincoln, 
NE, USA). Density profiles were determined by performing a sub-
traction of the background, integrating the pixel intensity across the 
area of the band, and dividing the intensity by the width of the band 
to control for variations in band size. GAPDH normalization was 
used as the loading control and for each sample expression of the 
synaptic proteins was divided by GAPDH expression. We verified 
that GAPDH expression was not correlated with age for any of the 
groups (all p-values were > 0.15) and thus was an appropriate loading 
control for this study. A control sample (a mixture of all the samples) 
was run on all of the gels and the density of each sample was measured 
relative to that control (sample density/control density).
We plotted scattergrams of Ube3A expression that included both 
the average expression level for each case and every point from all 
runs. To facilitate comparing the pattern of changes the results 
were normalized to the average for young adults. For humans, the 
young adult average was calculated from the 19-, 22-, and 32-year-
old samples. For cats, the 2.5-year-old samples, and for macaque 
monkeys, the 4-year-old samples. To help describe the pattern of 
change in expression across the lifespan a weighted average curve 
was fit to Ube3A expression using the locally weighted least squares 
method (dotted lines).
In order to quantify changes in Ube3A expression relative to 
a collection of other synaptic proteins, we calculated an index of 
Ube3A to the average of four other synaptic proteins ((Ube3A-
Other)/(Ube3A + Other)). The other synaptic proteins were syn-
apsin, synaptophysin, PSD-95, and gephyrin.
Statistical comparisons of differences in Ube3A expression levels 
between young vs old adults (human: young – 19–32 years, old 
– 50–79 years; macaque monkey: young – 4–13 years, old – 20–33 
years; cat: young – 2.5 years, old – 7–11 years) were calculated using 
Wilcoxon  Mann–Whitney  and  Kruskal–Wallis  non-parametric 
analysis of variance.
results
In this study, we characterized the expression of E3 ubiquitin ligase, 
Ube3A, in three different species: humans, macaque monkeys, 
and cats. These species are commonly used to study perceptual 
Table  | Monkey tissue samples.
Monkey age (years)  V  V3a  V4v
4      
13      
20      
25      
25      
27 .5      
30      
33      
The	age	and	cortical	area	of	the	tissue	samples.	The	star	()	indicates	that	a	
sample	was	obtained	from	that	visual	cortical	area.
Table 3 | Cat tissue samples.
Cat age (years)  V  A  Frontal
2.5      
2.5      
7 .3      
9      
10      
11      
11      
The	age	and	cortical	area	of	the	tissue	samples.	The	star	()	indicates	that	a	
sample	was	obtained	from	that	cortical	area.Frontiers in Aging Neuroscience  www.frontiersin.org  May 2010  | Volume 2  | Article 18  |  4
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and neurobiological changes in the aging visual system. Using 
Western blot analysis, we quantified the developmental trajectory 
of Ube3A expression across the lifespan. We measured expression 
in primary visual cortex (V1), because it is has been shown that 
Ube3A is required for experience-dependent plasticity in visual 
cortex (Yashiro et al., 2009). In the cat, we took samples from 
different regions of V1, to examine whether Ube3A might play a 
role in the loss of peripheral vision that occurs in normal aging 
(Sekuler et al., 2000). In the monkey and human, we took additional 
samples from dorsal (V3/V3a) and ventral (V4) visual processing 
streams. In the cat, we took additional samples from auditory and 
frontal cortex to examine Ube3A expression in other sensory and 
non-sensory cortical areas. Finally, to understand the expression of 
Ube3A in the context of other synaptic proteins over the lifespan, 
we quantified the expression of synapsin, synaptophysin, gephyrin, 
and PSD-95.
The  human  tissue  samples  were  collected  over  a  range  of 
postmortem intervals (4–23 h), but we found no significant cor-
relation between postmortem interval and expression of any of 
the proteins examined (all ps > 0.1): Ube3A (R = 0.23), GAPDH 
(R = 0.02),  Synapsin  (R = 0.22),  Synaptophysin  (R = 0.04), 
Gephyrin (R = 0.29), and PSD-95 (R = 0.08).
changes In ube3a expressIon In prIMary VIsual cortex (V1)
In human primary visual cortex (V1), we measured expression of 
Ube3A across the lifespan using Western blot analysis. No previous 
studies have examined the normal pattern of Ube3A expression 
in human V1, although other studies have shown that the loss of 
Ube3A expression during development leads to mental retardation 
(Angelman’s syndrome), and later disruptions in ubiquitin-mediated 
proteasomal degradation are linked with neurodegenerative disor-
ders. We plotted Ube3A expression as a function of age (range from 
20 days to 80 years), normalized relative to the expression level of 
young adults (19–32 years old) and fit with a locally weighted aver-
age curve (Figure 1). The average Ube3A expression in human V1 
was relatively constant in children, teenagers, and young adults, but 
there was substantial inter-individual variability in Ube3A expres-
sion at these younger ages. After the young adult years (>mid 30 s) 
there was a clear loss of Ube3A expression with aging; Ube3A expres-
sion in older adults (>50 years) fell to about 50% of the younger 
adult levels (p < 0.01). For the oldest case (79 years), the loss of 
Ube3A expression was substantial, with about 85% less expression 
relative to young adult levels. In addition, there was much less inter-
individual variability in older adults.
In macaque monkey V1, we quantified changes in Ube3A, and 
compared expression levels in young and older adults. The Ube3A 
expression levels were plotted relative to young adult expression, 
and a locally weighted average curve was fit to the data (Figure 2A). 
There was a significant loss (approximately 25% ± 5%) of Ube3A 
expression (p < 0.05) in old monkeys (>20 years), though, this loss 
was less than that found for human V1. The loss of Ube3A in aging 
monkey V1 occurred between 13 and 20 years of age when expres-
sion dropped by 25% and then remained at that level.
In cat V1, we quantified changes in Ube3A expression using 
multiple samples from different regions of V1, anticipating the 
possibility of regional differences related to the loss of peripheral 
vision in aging. Despite this expectation, we found no significant 
differences in Ube3A expression at any age between samples from 
parts of V1 that represent the central, peripheral, or monocu-
lar visual field (p > 0.1). Therefore, Ube3A expression from all 
regions of cat V1 were combined, normalized relative to the young 
adult cat level (2.5 years), and fit with a locally weighted aver-
age curve (Figure 2B). We found a substantial loss of Ube3A 
expression after 2.5 years of age (p < 0.001). In cat V1, Ube3A 
expression levels fell an average of 45% (±7%) during aging. The 
magnitude of the age-related loss of Ube3A expression in cat V1 
was greater than monkeys and comparable to the loss found in 
older human V1.
changes In ube3a expressIon In extrastrIate areas V3 and V4
To examine whether there were age-related losses of Ube3A expres-
sion in extrastriate visual areas we quantified expression in areas V3 
and V4v of macaque monkey and human cortex. These areas repre-
sent early stages in the dorsal (V3) and ventral visual streams (V4v). 
The Ube3A expression levels were plotted relative to young adult 
expression, and a weighted average was fit to the data (Figure 3).
In monkey V3, there was no significant difference in Ube3A 
expression between the young (4 year old) and older monkeys 
(>20 years). Closer inspection of the results (Figure 3A) showed 
that one older monkey (30 years) had no loss, but the expression 
levels for the other five older monkeys had declined by about 50% 
(p < 0.06). In monkey V4, Ube3A expression declined steadily dur-
ing aging (Figure 3A) falling an average of 55% (p < 0.05). The loss 
of Ube3A in monkey V4 was about twice as large as the loss in V1, 
and it occurred by 13 years of age, which was earlier than the onset 
of the loss in monkey V1.
FigUrE  | Ube3A expression level in human primary visual cortex 
across the lifespan. Expression levels are relative to young adults, and a 
weighted average was fit. Gray symbols indicate values from individual runs, 
black symbols represent the average between runs. Age is plotted on a 
logarithmic scale. Representative Western blots are pictured above. 
Expression was relatively constant through childhood to teenage to young 
adult levels. There was a clear loss of Ube3A in aging when expression fell 
nearly 50% from young adult levels (p < 0.01). In the oldest case (79 years) 
expression fell approximately 85%.Frontiers in Aging Neuroscience  www.frontiersin.org  May 2010  | Volume 2  | Article 18  |  
Williams et al.  Ube3A expression in aging cortex
The  analysis  of  Ube3A  expression  in  human  V3  and  V4 
included samples covering ages from 8 to 80 years of age. The 
Ube3A expression levels in both V3 and V4 were relatively con-
stant through childhood, teenage, young adults years (Figure 
3B). Similar to the expression pattern in V1, there was substantial 
inter-individual variability in Ube3A expression in areas V3 and 
V4 for these younger cases. After the young adult years there 
was a steady loss of Ube3A expression in both V3 (p < 0.05) 
and V4 (p < 0.01) of human cortex (Figure 3B) and less inter-
individual variability. When compared to the young adults, the 
Ube3A expression in V3 and V4 of the oldest case (79 years) had 
fallen by 75–80%.
ube3a expressIon In audItory and Frontal cortex
In cat auditory and frontal cortex, we quantified the expression 
of Ube3A in order to determine whether other sensory and non-
sensory cortical areas had age-related losses similar to V1. Ube3A 
expression was plotted relative to young adult (2.5 years) expression, 
and a locally weighted average curve was fit to the data (Figure 4). 
FigUrE  | Ube3A expression level in primary visual cortex across the 
lifespan of cat and macaque monkey. Expression levels are relative to young 
adults, and a weighted average was fit. Gray symbols indicate values from 
individual runs, black symbols represent the average between runs. 
Representative Western blots are pictured above. In monkey, expression fell 
approximately 25% (p < 0.05) in old monkeys (>20 years). This occurred 
between 13 and 20 years of age (A). In cat, expression fell approximately 45% 
during aging (p < 0.001). This occurred between 2.5 and 7 years of age (B).
FigUrE 3 | Ube3A expression in V3 and V4 of human and macaque 
monkey. Expression levels are relative to young adults, and a weighted 
average was fit. The larger green squares represent V3 and the larger red 
triangles represent V4. Individual runs are represented in the corresponding 
lighter shades. Age is plotted on a logarithmic scale for human V3, V4. 
Representative Western blots are pictured above. White asterisks indicate that 
no sample was acquired for that age. In monkey V3, there was no significant 
difference between young (4 year old) and older monkeys (<20 years). In 
monkey V4, Ube3A expression steadily declined during aging falling on 
average by 55% in older monkeys (p < 0.05) (A). In human, Ube3A expression 
in both V3 and V4 remained relatively constant through childhood to teenage 
to young adult. There was a steady loss into aging (p < 0.05) (B).Frontiers in Aging Neuroscience  www.frontiersin.org  May 2010  | Volume 2  | Article 18  |  6
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In auditory cortex, the loss of Ube3A began between 7.5 and 9 years 
of age, when it dropped about 60% (±8%) relative to young adult 
cat levels (p < 0.01). In frontal cortex Ube3A expression had already 
declined by 7.5 years of age and continued to decline in the older 
cats. Expression of Ube3A in older cat frontal cortex was about 60% 
(±10%) less than levels in young adults (p < 0.05). In both frontal 
and auditory cortex, the magnitude of the loss was comparable to 
the loss in cat V1.
ube3a expressIon relatIVe to other synaptIc proteIns
To address whether the age-related losses we observed were specific 
to Ube3A expression, or reflected a more general loss of synaptic 
proteins, we calculated an index of Ube3A expression relative to 
the expression of four other synaptic proteins (synapsin, synapto-
physin, gephyrin, PSD-95). For this index, positive values indicate 
relatively more Ube3A and negative values indicate less Ube3A 
relative to the other synaptic proteins.
In monkey V1, there was no selective loss of Ube3A relative 
to the other synaptic proteins (Figure 5A). The index remained 
close to 0, indicating that Ube3A expression and the other synaptic 
proteins were roughly balanced across younger and older monkeys. 
A similar pattern was observed for cat auditory and frontal cortex 
(Figure 5B) with a slight trend towards less relative Ube3A expres-
sion in aging. A different pattern was found for cat V1, where at the 
oldest age (11 years) there was a significant loss of Ube3A relative 
to the other synaptic proteins (p < 0.05), dropping by an average 
of 40% (Figure 5C). This indicates a selective loss of Ube3A dur-
ing aging of cat V1.
FigUrE 4 | Ube3A expression in frontal and auditory cortex of cat. 
Expression levels are relative to young adults, and a weighted average was fit. 
The larger black triangles represent frontal cortex and the larger black squares 
represent auditory cortex. Individual runs are represented in the 
corresponding gray symbols. Representative Western blots are pictured 
above. Expression in frontal cortex began to decline after 2.5 years of age and 
continued to decline in aging where it fell by approximately 60% (p < 0.05). 
Expression in auditory cortex began to decline after 7 .5 years where it fell by 
approximately 60% (p < 0.05). Expression at age 2.5 for both auditory and 
frontal cortex was so similar the symbols completely overlap.
FigUrE  | index between Ube3A and other synaptic proteins (synapsin, 
gephyrin, PSD-9) for macaque monkey V, cat frontal and auditory 
cortex, and V. Positive values indicate relatively more Ube3A expression, 
negative values indicate relatively less Ube3A expression. Gray symbols 
indicate values from individual runs, black symbols represent the average 
between runs. A weighted average was fit to the data. In monkey V1, there 
was no selective loss in Ube3A (A). Both frontal and auditory cortex showed a 
slight trend towards relatively less Ube3A expression with age (B). In V1, 
there was a significant loss of Ube3A in the oldest cat (11 years of age) 
relative to other synaptic proteins, dropping on average 40% (p < 0.05) (C).Frontiers in Aging Neuroscience  www.frontiersin.org  May 2010  | Volume 2  | Article 18  |  
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In human V1, there was a clear developmental change in the 
expression of Ube3A relative to other synaptic proteins (Figure 
6A). At the youngest ages (<1 year), there was more Ube3A; in 
children through to pre-teen years, Ube3A expression was roughly 
in balance with other synaptic proteins; in teens and young adults, 
relative Ube3A expressions dropped slightly, and then fell off sub-
stantially in aging (p < 0.0001). A very similar pattern was found 
for human V3 and V4 (Figure 6B). In teens and young adults, the 
expression of Ube3A was roughly balanced with expression of 
other synaptic proteins and then there was a shift to relatively less 
Ube3A expression in older human V3 and V4 (p < 0.01). These 
results show a selective loss of Ube3A in human visual areas dur-
ing aging.
dIscussIon
Our study found that Ube3A expression declines across the lifespan 
in human, monkey, and cat cortex. This occurred in visual areas 
V1, V3, and V4, as well as frontal and auditory cortex. Moreover, in 
human areas V1, V3, and V4 there was a much greater loss of Ube3A 
relative to other synaptic proteins. This is the first study to address 
how the E3 ubiquitin ligase, Ube3A, changes in healthy aging. Our 
findings identify a fundamental change in Ube3A expression in the 
aging cortex and give new insights into age-related changes that 
lead to the loss of synaptic plasticity.
ube3a loss: sIMIlarItIes and dIFFerence
We have identified many similarities, and a key difference, in age-
related changes of Ube3A expression among the cortical areas, animal 
models, and human cortex. The large number of samples for human 
V1, ranging from 20 days to 80 years of age, give a comprehensive 
view of the trajectory of Ube3A expression in human cortex. There 
was a clear loss of Ube3A expression with aging in all three species and 
in all cortical areas. A common notion is that the whole synaptic pro-
teome goes down during aging. In the animals models, much of the 
loss can be explained by a general loss of synaptic proteins. In human 
cortex, however, there was a selective loss of Ube3A. For human visual 
cortical areas, the loss of Ube3A was substantially greater than the loss 
of other synaptic proteins. These results are suggestive of a general 
cortical pattern of synaptic change that may help to explain age-
related functional losses in learning and memory, as well as other 
sensory systems. A diffuse loss of Ube3A across the human cortex 
may underlie a common mechanism affecting synaptic plasticity and 
mediating age-related functional losses. The loss of Ube3A during 
normal aging may lead to rigid synapses similar to Ube3A KO mice 
that lack synaptic plasticity (Yashiro et al., 2009).
A richer picture of the aging synapse is emerging from recent 
studies examining changes in synaptic proteins. The pattern of 
change is one of selective losses rather than a general decline in syn-
aptic proteins. For example, there are selective pre- and post-synap-
tic changes in GABAergic signaling mechanisms during aging that 
will affect the functioning of cortical inhibition (Pinto et al., 2010). 
These selective changes at aging synapses have specific implications 
for dynamic synaptic function, as the relative balance between pro-
teins changes and reduces experience-dependent plasticity.
ube3a loss reduces experIence-dependent plastIcIty
Although Ube3A is required for experience-dependent plasticity 
during development of the visual cortex (Yashiro et al., 2009), the 
precise role that Ube3A plays is unclear. Ube3A knockout mice have 
deficits in LTP, despite normal baseline neurotransmission, and they 
display deficits in context dependent learning (Jiang et al., 1998). In 
addition, the development of dendritic spines is abnormal with fewer 
spines and abnormal spine morphologies in Ube3A knockout mice 
(Dindot et al., 2008). Together, these results point to a role for Ube3A 
in local regulation of synaptic plasticity. An important insight into the 
function of Ube3A comes from studying ocular dominance plasticity 
in the Ube3A knockout mice (Yashiro et al., 2009). They lack ocular 
dominance plasticity when reared in the light, but when dark reared 
and then brought into the light, these animals show the typical shift 
of ocular dominance in response to closing one eye. This experience-
dependent plasticity, however, is lost after just a few days in the light 
FigUrE 6 | index between Ube3A and other synaptic proteins (synapsin, 
gephyrin, PSD9, synaptophysin) in human V, V3, V4. Positive values 
indicate relatively more Ube3A expression, negative values indicate relatively 
less Ube3A expression. The larger green squares represent V3 and the larger 
red triangles represent V4. Individual runs are represented in the 
corresponding lighter shades. A weighted average was fit to the data. Age is 
plotted on a logarithmic scale. The shaded area represented ages we do not 
have data for. In human V1, at the youngest ages there was more Ube3A, in 
children to pre-teens the expression was balanced, in teens to young adults it 
shifts in favor of less Ube3A, and falls off in aging (>50 years old) (p < 0.0001) 
(A). In V3, V4 expression was balanced in teens and young adults, and fell to 
less Ube3A in older humans (>50 years old) (p < 0.01) (B).Frontiers in Aging Neuroscience  www.frontiersin.org  May 2010  | Volume 2  | Article 18  |  
Williams et al.  Ube3A expression in aging cortex
and once again the synapses become rigid, unable to adapt to experi-
ence (Yashiro et al., 2009). Simply using the synapses depletes them 
of plasticity. This leaves neural connections in the cortex rigid, unable 
to be fine tuned and to develop normal function. Ube3A mediates 
plasticity at excitatory synapses by controlling the degradation of Arc 
which effects the internalization of AMPA receptors. Thus, disrupt-
ing Ube3A function causes an increase in Arc expression leading to 
greater internalization of AMPA receptors and loss of AMPA receptor 
at excitatory synapses (Greer et al., 2010). Perhaps the rigid synapses 
found in the Ube3A knockout mice are the key to linking the loss of 
Ube3A expression during normal aging of human cortex with the 
rigid behaviors that often accompany aging.
VIsual changes In agIng
The time course of loss in Ube3A expression is similar to the decline 
of visual abilities in aging. There are a wide range of visual deficits 
in aging which suggests that widespread neural changes occur across 
the central visual pathway. Certain visual perceptions, however, are 
more vulnerable to the effects of aging (Faubert, 2002; Billino et al., 
2008). Specifically, the processing of complex visual stimuli declines 
more than the perception of simple visual stimuli, suggesting that 
complex neural integration may be more affected by aging (Habak and 
Faubert, 2000). For example, the perception of a moving stimulus that 
is surrounded by other moving stimuli is particularly affected in aging 
(Betts et al., 2005), raising the possibility that aging affects dynamic 
neural processing in the visual system. In this framework, the loss of 
Ube3A during aging may reduce the capacity for experience driven 
dynamic synaptic changes that are necessary to integrate and adapt 
physiological response in the visual cortex (Fu et al., 2002).
lInks between ube3a and gabaergic changes In agIng
The most common explanation for age-related changes in visual 
perceptual is a loss of GABA-mediated inhibition (Betts et al., 
2005). This idea comes from studies showing that the direct appli-
cation of GABA onto cortical neurons improves the neurophysi-
ological responses of individual V1 neurons in senescent monkeys 
(Leventhal et al., 2003). Additionally, the loss of GABA-mediated 
inhibition in aging is further supported by a loss of GABAergic 
neurons in visual cortex of older cats (Hua et al., 2008), and a loss of 
specific synaptic components of GABAergic signaling during aging 
of human visual cortex (Pinto et al., 2010). The current findings 
of a loss of Ube3A, broadens our understanding of the age-related 
changes in visual cortex by showing synaptic compromises beyond 
changes in GABAergic signaling mechanisms.
It seems likely that changes at the aging synapse are as complex 
as those during development. The challenge for understanding 
aging visual perception will be to determine if particular perceptual 
losses are linked with specific changes in visual cortical synapses. 
There are interesting parallels in the development of experience-
  dependent plasticity between mice lacking GAD65 or Ube3A. Mice 
lacking GAD65, the enzyme that synthesizes the on-demand pool of 
GABA, have reduced inhibitory transmission and are insensitive to 
monocular deprivation (Hensch et al., 1998). But ocular dominance 
plasticity is re-established in GAD65 knockout mice, at any age, 
by infusion of diazepam into the visual cortex to increase GABA-
mediated activity. Similarly, Ube3A knockout mice fail to express 
ocular dominance plasticity in development, but this plasticity can 
be restored by dark rearing (Yashiro et al., 2009). Perhaps future 
studies that compare the similarities and differences in experience-
dependent plasticity in these mouse models will help to inform our 
understanding of the functional changes in aging synapses.
what Is the nature oF ube3a loss In agIng?
While the rigid synaptic plasticity found in Ube3A knockout mice 
provides a promising model for understanding experience-dependent 
changes in aging synapses there is an important difference to consider. 
Plasticity is preserved in Ube3A mice by restricting experience. At first 
glance, this seems counter to our current thinking that the best way 
to preserve brain function during aging is to engage in activities to 
keep the mind active (Fratiglioni et al., 2004). Clearly, the age-related 
loss in Ube3A must be more complex than simply losing Ube3A at 
all synapses. An intriguing possibility is that age-related Ube3A loss 
is synapse-specific, and it is lost at some synapses and retained at 
others. This would lead to a situation where some synapses have 
reduced capacity for experience-dependent plasticity and become 
rigid, while others maintain a normal level of plasticity. The changes 
could be widespread and random, or particular circuits may be more 
vulnerable to the loss of Ube3A. If the latter is true, then insights into 
what makes a particular circuit or synapse more likely to lose Ube3A 
becomes a new and important question for understanding healthy 
aging. This is particularly interesting in light of a recent study in C. 
elegans showing that an E3 ligase homologous to Ube3A is necessary 
for caloric restriction to extend longevity (Carrano et al., 2009).
The current results raise questions about what drives the loss of 
Ube3A in the cortex during aging. It will be important to address 
this while considering strategies to prevent the loss or increase 
expression of Ube3A in the aging cortex. The loss may reflect a 
generalized down-regulation of cellular function and the ubiq-
uitination machinery during aging. It seems likely that this will 
account for some of the loss but probably not all of it since we 
found a much greater loss of Ube3A relative to other synaptic 
proteins in human cortex. Another possibility is that age-related 
degradation of sensory and/or cognitive functions drives an experi-
ence-dependent loss of Ube3A. Two recent studies provide some 
insights about the impact of experience on Ube3A expression. One 
study found that enriched experience in adult mice increases Ube3A 
expression in the hippocampus (Greer et al., 2010) while the other 
study showed that early monocular deprivation does not lead to a 
loss of Ube3A (Sato and Stryker, 2010). These contrasting results 
indicate that more work is needed to determine the full scope of 
experience-dependent changes in Ube3A expression in the brain. 
One possibility is that the role of experience in regulating Ube3A 
expression changes across the lifespan so that it has greater impact 
in the adult brain.
The progressive loss of Ube3A expression during cortical aging 
is an important new finding for understanding age-related losses in 
experience-dependent synaptic plasticity. Furthermore, the selec-
tive loss of Ube3A in human cortex highlights a particular vulner-
ability in human brain aging that may signify a shift in cortical 
function and selective loss of synaptic plasticity.
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